Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
CytoDyn Inc. (CYDY) had Weighted-Average Shares Outstanding (Diluted) of 1.24B for the most recently reported fiscal year, ending 2025-05-31.
| Income Statement Financials | |
-- |
|
$3.75M |
|
-- |
|
-- |
|
$-9.66M |
|
$9.66M |
|
$-5.92M |
|
$3.75M |
|
$3.34M |
|
$3.75M |
|
$3.75M |
|
$3.75M |
|
$3.34M |
|
$9.66M |
|
$10.09M |
|
1.21B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.24B |
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$17.88M |
|
-- |
|
$0.17M |
|
$18.05M |
|
$70.52M |
|
-- |
|
$43.57M |
|
$114.09M |
|
$-96.04M |
|
$-96.04M |
|
$-96.04M |
|
1.25B |
|
| Cash Flow Statement Financials | |
$-8.77M |
|
-- |
|
$10.85M |
|
$9.81M |
|
$11.90M |
|
$2.09M |
|
$1.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
-0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.90% |
|
-3.90% |
|
20.75% |
|
-3.90% |
|
$-0.08 |
|
$-0.01 |
|
$-0.01 |
|